Attgeno AB, home of Supernitro, is a Swedish clinical stage pharmaceutical company developing innovative nitric oxide (NO)-donating technology and products, with a focus on treating acute pulmonary hypertension
Attgeno AB, home of Supernitro, is a Swedish clinical stage pharmaceutical company developing innovative nitric oxide (NO)-donating technology and products, with a focus on treating acute pulmonary hypertension.